1287700
USP
Galactose
United States Pharmacopeia (USP) Reference Standard
Sign Into View Organizational & Contract Pricing
All Photos(1)
Synonym(s):
α-D-Galactose, α-D-Galactopyranose
Empirical Formula (Hill Notation):
C6H12O6
Recommended Products
grade
pharmaceutical primary standard
API family
galactose
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
InChI
1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5-,6+/m1/s1
InChI key
WQZGKKKJIJFFOK-PHYPRBDBSA-N
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Galactose contains d-galactopyranose (C6H12O6), which is obtained either as one of the products of the metabolism of lactose, a naturally occurring sugar in dairy products, by the digestive enzyme lactase, or from arabinogalactans isolated from a plant-derived source.
Galactose contains d-galactopyranose (C6H12O6), which is obtained either as one of the products of the metabolism of lactose, a naturally occurring sugar in dairy products, by the digestive enzyme lactase, or from arabinogalactans isolated from a plant-derived source.
Application
Galactose USP reference standard intended for use in specified quality tests and assays.
Also used to prepare standard, standard solution A, standard solution B, standard stock, and system suitability solution for assay during thin-layer chromatography (TLC) identification test according to the given below monographs of United States Pharmacopeia (USP):
Also used to prepare standard, standard solution A, standard solution B, standard stock, and system suitability solution for assay during thin-layer chromatography (TLC) identification test according to the given below monographs of United States Pharmacopeia (USP):
- Galactose
- Guar Gum
- Lactulose Concentrate
- Ganoderma Lucidum Fruiting Body Powder
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Other Notes
Sales restrictions may apply.
related product
Product No.
Description
Pricing
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Regulatory Information
监管及禁止进口产品
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Ganoderma Lucidum Fruiting Body Powder
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 40(5), 5008-5008 (2015)
Lactulose Concentrate
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 40(5), 2521-2521 (2016)
Galactose
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 44(5) (2020)
Guar Gum
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 41(2), 5813-5813 (2018)
Michelle P Christie et al.
PloS one, 9(4), e95024-e95024 (2014-04-17)
Glycosylation of biopharmaceuticals can mediate cell specific delivery by targeting carbohydrate receptors. Additionally, glycosylation can improve the physico-chemical (drug-like) properties of peptide based drug candidates. The main purpose of this study was to examine if glycosylation of the peptide enkephalin
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service